| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Department of Biochemistry and Molecular Biophysics, Howard Hughes Medical Institute, Columbia University, College of Physicians and Surgeons, New York, NY 10032 USA; Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP/Collège de France, BP10142, 67404 Illkirch-Cedex, France
* To whom correspondence should be addressed. Email:
goff{at}cancercenter.columbia.edu.
TRIM28 is a transcriptional co-repressor which is required for primer bind site (PBS)-dependent restriction of murine leukemia virus (MLV) replication in embryonic stem (ES) and embryonic carcinoma (EC) cells. PBS-dependent restriction of MLV leads to transcriptional silencing of the integrated provirus and has been shown to correlate with TRIM28-mediated recruitment of HP1 to the silenced loci. Here we show using a cell line with a point mutation in the HP1 binding domain of TRIM28 that interaction with HP1 is absolutely required for PBS-dependent restriction of MLV in the F9 EC cell line.
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
PBS-dependent Restriction of Murine Leukemia Virus Requires HP1 Binding by TRIM28
![]()
Abstract
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|